CRL
Price
$179.98
Change
+$5.19 (+2.97%)
Updated
Jun 3, 04:59 PM (EDT)
Capitalization
8.42B
70 days until earnings call
Intraday BUY SELL Signals
CTKB
Price
$4.04
Change
-$0.14 (-3.34%)
Updated
Jun 3, 01:06 PM (EDT)
Capitalization
547.56M
70 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRL vs CTKB

Header iconCRL vs CTKB Comparison
Open Charts CRL vs CTKBBanner chart's image
CRL vs CTKB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CRL vs. CTKB commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and CTKB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2026
Stock price -- (CRL: $174.79 vs. CTKB: $4.20)
Brand notoriety: CRL and CTKB are both not notable
CRL represents the Medical Specialties, while CTKB is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: CRL: 82% vs. CTKB: 102%
Market capitalization -- CRL: $8.42B vs. CTKB: $547.56M
CRL [@Medical Specialties] is valued at $8.42B. CTKB’s [@Medical/Nursing Services] market capitalization is $547.56M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $151.49B to $0. The average market capitalization across the [@Medical Specialties] industry is $14.59B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 1 FA rating(s) are green whileCTKB’s FA Score has 0 green FA rating(s).

  • CRL’s FA Score: 1 green, 4 red.
  • CTKB’s FA Score: 0 green, 5 red.
According to our system of comparison, CRL is a better buy in the long-term than CTKB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 6 TA indicator(s) are bullish while CTKB’s TA Score has 5 bullish TA indicator(s).

  • CRL’s TA Score: 6 bullish, 4 bearish.
  • CTKB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, CRL is a better buy in the short-term than CTKB.

Price Growth

CRL (@Medical Specialties) experienced а +11.52% price change this week, while CTKB (@Medical/Nursing Services) price change was +5.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.33%. For the same industry, the average monthly price growth was +17.05%, and the average quarterly price growth was -4.52%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.50%. For the same industry, the average monthly price growth was -0.48%, and the average quarterly price growth was -16.35%.

Reported Earning Dates

CRL is expected to report earnings on Aug 12, 2026.

CTKB is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Medical Specialties (+1.33% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Medical/Nursing Services (-0.50% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($8.42B) has a higher market cap than CTKB($548M). CRL YTD gains are higher at: -12.377 vs. CTKB (-16.931). CRL has higher annual earnings (EBITDA): 291M vs. CTKB (-23.6M). CTKB has more cash in the bank: 262M vs. CRL (192M). CTKB has less debt than CRL: CTKB (27.5M) vs CRL (3.06B). CRL has higher revenues than CTKB: CRL (4.03B) vs CTKB (204M).
CRLCTKBCRL / CTKB
Capitalization8.42B548M1,536%
EBITDA291M-23.6M-1,233%
Gain YTD-12.377-16.93173%
P/E Ratio577.05N/A-
Revenue4.03B204M1,974%
Total Cash192M262M73%
Total Debt3.06B27.5M11,113%
FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRLCTKB
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
69%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
70%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
70%
Bearish Trend 21 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRL
Daily Signal:
Gain/Loss:
CTKB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VET11.730.08
+0.69%
Vermilion Energy
CCIXU10.84N/A
N/A
Churchill Capital Corp IX
KNOP10.75-0.22
-2.01%
Knot Offshore Partners LP
SCYX5.10-0.23
-4.32%
SCYNEXIS Inc
TEM49.62-3.18
-6.02%
Tempus AI Inc.

CTKB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with CRL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
-1.06%
CRL - CTKB
44%
Loosely correlated
-4.00%
RVTY - CTKB
42%
Loosely correlated
-0.13%
BRKR - CTKB
40%
Loosely correlated
-1.93%
A - CTKB
39%
Loosely correlated
-0.68%
UTMD - CTKB
38%
Loosely correlated
+1.39%
More